EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity

Brondwyn S McGhie iD, Jennette Sakoff iD, Jayne Gilbert iD, Christopher P Gordon iD, Janice R Aldrich-Wright iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Brondwyn S McGhie und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Nanoscale Organisation and Dynamics Group, Western Sydney University, Locked Bag 1797 Penrith South DC, Penrith, NSW 2751, Austral…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer poses a significant threat to global health and new treatments are required to improve the prognosis for patients. Previously, unconventional platinum complexes designed to incorporate polypyridyl ligands paired with diaminocyclohexane have demonstrated anticancer activity in KRAS mutated cells, previously thought to be undruggable and have cytotoxicity values up to 100 times better than cisplatin. In this work, these complexes were used as inspiration to design six novel cyclometallated examples, whose fluorescence could be exploited to better understand the mechanism of action of these kinds of platinum drugs. The cytotoxicity results revealed that these cyclometallated complexes (CMCs) have significantly different activity compared to the complexes that inspired them; they are as cytotoxic as cisplatin and have much higher selectivity indices in breast cancer cell lines (MCF10A/MCF-7). Complexes 1b, 2a, and 3b all had very high selectivity indexes compared to previous Pt(II) complexes. This prompted further investigation into their DNA binding properties, which revealed that they had good affinity to ctDNA, especially CMCs 1a and 3b. Their inherent fluorescence was successfully utilised in the calculation of their DNA binding affinity and could be useful in future work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsCoordination ComplexesHumansCisplatinPlatinumDNACell Line, Tumor

Stichwörter der Autor:innen

anticancercyclometallatedplatinum

Substanzen

CisplatinPlatinumAntineoplastic AgentsDNACoordination Complexes

Autor:innen und Institutionen

  • School of Science, Nanoscale Organisation and Dynamics Group, Western Sydney University, Locked Bag 1797 Penrith South DC, Penrith, NSW 2751, Australia.
  • Calvary Mater Newcastle, Waratah, Newcastle, NSW 2298, Australia.

ORCID-Profile: Brondwyn S McGhie, Jennette Sakoff, Jayne Gilbert, Christopher P Gordon, Janice R Aldrich-Wright

Zitieren

APA

McGhie, B. S., Sakoff, J., Gilbert, J., Gordon, C. P., & Aldrich-Wright, J. R. (2023). Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098049

Vancouver

McGhie BS, Sakoff J, Gilbert J, Gordon CP, Aldrich-Wright JR. Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098049

BibTeX
@article{McGhie2023,
  author = {McGhie, Brondwyn S and Sakoff, Jennette and Gilbert, Jayne and Gordon, Christopher P and Aldrich-Wright, Janice R},
  title = {Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098049}
}
Kostenlos starten →